Form 424B5 Pyxis Oncology, Inc.

Go back to Form 424B5 Pyxis Oncology, Inc.

Pyxis Oncology terminates $150M ATM stock offering program

September 29, 2026 4:24 PM EDT

Pyxis Oncology (NASDAQ: PYXS) has terminated a continuous at-the-market stock offering program that had been set up to raise up to $150 million, according to a filing with the Securities and Exchange Commission.

The company had entered into a Sales Agreement with Leerink... More